Erratum: High-sensitivity cardiac troponin assays: Answers to frequently asked questions (Archives of Cardiovascular Diseases (2015) 108 (132-149) (DOI:10.1016/j.acvd.2014.11.001));High-sensitivity cardiac troponin assays: Answers to frequently asked questions

Archives of Cardiovascular Diseases

Volumn 108, Issue 2, 2015, Pages 132-149

  Chenevier Gobeaux, Camille ^a   Bonnefoy Cudraz, Éric ^b   Charpentier, Sandrine ^c   Dehoux, Monique ^d   Lefevre, Guillaume ^e   Meune, Christophe ^f,g   Ray, Patrick ^e,h,i  

^a HÔTEL DIEU   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c CHU RANGUEIL   (France)

^d BICHAT HOSPITAL   (France)

^e HÔPITAL TENON   (France)

^f AVICENNE HOSPITAL   (France)

^g UNIVERSITÉ PARIS 13   (France)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Acute coronarysyndrome; Chest pain; High sensitivity; Myocardialinfarction; Troponin

Indexed keywords

TROPONIN; BIOLOGICAL MARKER; TROPONIN T;

ACCURACY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE NECROSIS; HIGH SENSITIVITY CARDIAC TROPONIN ASSAY; HUMAN; LIMIT OF DETECTION; PATHOPHYSIOLOGY; POINT OF CARE TESTING; PROGNOSIS; QUANTITATIVE ASSAY; REVIEW; THORAX PAIN; BLOOD; HOSPITAL INFORMATION SYSTEM; IMMUNOASSAY; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; SENSITIVITY AND SPECIFICITY; STANDARDS;

BIOLOGICAL MARKERS; HUMANS; IMMUNOASSAY; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY; TROPONIN; TROPONIN T;

EID: 84923776347     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2015.05.001     Document Type: Erratum

References (50)

1. Apple FS, Wu AH, Jaffe AS, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation 2007;116:e95-8.
2. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
3. Tate J. Troponin Assay Analytical Characteristics 2013. Milano, Italy: IFCC. Available at http://www.ifcc.org/ifcc-scientific-division/documents-of-the-sd/troponinassayanalyticalchara cteristics2013/ [accessed date: 25th April 2014].
4. Koerbin G, Tate J, Potter JM, Cavanaugh J, Glasgow N, Hickman PE. Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population. Clin Chem Lab Med 2012;50:871-8.
5. Thygesen K, Mair J, Giannitsis E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012;33:2252-7.
6. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
7. Pajunen P, Koukkunen H, Ketonen M, et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005;12:132-7.
8. Cardinaels EP, Mingels AM, Jacobs LH, Meex SJ, Bekers O, van Dieijen-Visser MP. A comprehensive review of upper reference limits reported for (high-)sensitivity cardiac troponin assays: the challenges that lie ahead. Clin Chem Lab Med 2012;50:791-806.
9. Collinson PO, Heung YM, Gaze D, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012;58:219-25.
10. Horowitz GL, Altaie S, Boyd JC, et al. Defining, establishing and verifying reference intervals in the clinical laboratory; approved guideline. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI) document EP28-A3c; 2008.
11. Clerico A, Giannoni A, Prontera C, Giovannini S. High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice. Adv Clin Chem 2009;49:1-30.
12. Irfan A, Twerenbold R, Reiter M, et al. Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain. Am J Med 2012;125:491-8 [e1].
13. Menacer S, Claessens YE, Meune C, et al. Reference range values of troponin measured by sensitive assays in elderly patients without any cardiac signs/symptoms. Clin Chim Acta 2013;417:45-7.
14. Comité Européen de Normalisation. Laboratoires de biologie médicale: exigences concernant la qualité et la compétence. La Plaine Saint Denis, France: AFNOR, éditions AFNOR; 2012. ISO 15189. Available at: http://www.boutique.afnor.org/ norme/nf-en-iso-15189/laboratoires-de-biologie-medicale-exigences-concernant-la-qualite-et-la-competence/article/ 678634/fa157270
15. Ray P, Le Manach Y Riou B, Houle TT. Statistical evaluation of a biomarker. Anesthesiology 2010;112:1023-40.
16. Reiter M, Twerenbold R, Reichlin T et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011;32:1379-89.
17. Meune C, Balmelli C, Vogler E, et al. Consideration of high-sensitivity troponin values below the 99th percentile at presentation: does it improve diagnostic accuracy? Int J Cardiol 2013;168:3752-7.
18. Twerenbold R, Jaffe A, Reichlin T Reiter M, Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J 2012;33:579-86.
19. de Lemos JA. Increasingly sensitive assays for cardiac troponins: a review. JAMA 2013;309:2262-9.
20. Keller T Zeller T Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
21. Reichlin T Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
22. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
23. Chenevier-Gobeaux C, Meune C, Freund Y et al. Influence of age and renal function on high-sensitivity cardiac troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction. Am J Cardiol 2013;111:1701-7.
24. Reichlin T, Schindler C, Drexler B, et al. One-hour rule out and rule in of acute myocardial infarction using high-sensitivity cardiac troponin T Arch Intern Med 2012;172: 1211-8.
25. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press; 2001. P. 75.
26. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009;55:52-8.
27. Scharnhorst V, Krasznai K, van't Veer M, Michels RH. Variation of cardiac troponin I and T measured with sensitive assays in emergency department patients with noncardiac chest pain. Clin Chem 2012;58:1208-14.
28. Vasile VC, Saenger AK, Kroning JM, Klee GG, Jaffe AS. Biologic variation of a novel cardiac troponin I assay. Clin Chem 2011;57:1080-1.
29. Reichlin T, Irfan A, Twerenbold R, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011;124:136-45.
30. Mueller M, Biener M, Vafaie M, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012;58:209-18.
31. Wildi K, Reichlin T Twerenbold R, et al. Serial changes in high-sensitivity cardiac troponin I in the early diagnosis of acute myocardial infarction. Int J Cardiol 2013;168:4103-10.
32. Keller T Zeller T Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-93.
33. Biener M, Mueller M, Vafaie M, et al. Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule out and rule in of non-STEMI in an unselected emergency department population. Int J Cardiol 2013;167:1134-40.
34. Kelley WE, Januzzi JL, Christenson RH. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 2009;55:2098-112.
35. Wu AH. Interpretation of high-sensitivity cardiac troponin I results: reference to biological variability in patients who present to the emergency room with chest pain: case report series. Clin Chim Acta 2009;401:170-4.
36. Boden H, Ahmed TA, Velders MA, et al. Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention. Am J Cardiol 2013;111:1387-93.
37. Conde D, Costabel JP, Campos R, Trivi M. High-sensitive troponin T levels and complex coronary lesions. Am J Emerg Med 2013;31:1141.
38. Conde D, Elissamburu P, Lalor N, Rodriguez L. Fourth-generation troponin I and infarct size in patients with ST-elevation myocardial infarction. Am J Emerg Med 2014;32:467.
39. Bates KJ, Hall EM, Fahie-Wilson MN, et al. Circulating immunoreactive cardiac troponin forms determined by gel filtration chromatography after acute myocardial infarction. Clin Chem 2010;56:952-8.
40. Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T J Am Coll Cardiol 2011;58:1819-24.
41. Hickman PE, Potter JM, Aroney C, et al. Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta 2010;411:318-23.
42. Omland T de Lemos JA, Sabatine MS, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:2538-47.
43. Saunders JT, Nambi V, de Lemos JA, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011;123:1367-76.
44. de Lemos JA, Drazner MH, Omland T et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:2503-12.
45. Wallace TW, Abdullah SM, Drazner MH, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-65.
46. Haaf P, Drexler B, Reichlin T et al. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac non-coronary artery disease. Circulation 2012;126:31-40.
47. Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009;402:88-93.
48. Florkowski C, Wallace J, Walmsley T George P. The effect of hemolysis on current troponin assays - a confounding preana- lytical variable? Clin Chem 2010;56:1195-7.
49. Adamczyk M, Brashear RJ, Mattingly PG. Coprevalence of autoantibodies to cardiac troponin I and T in normal blood donors. Clin Chem 2010;56:676-7.
50. Bingisser R, Cairns C, Christ M, et al. Cardiac troponin: a critical review of the case for point-of-care testing in the ED. Am J Emerg Med 2012;30:1639-49.